Bufalin attenuates triple-negative breast cancer cell stemness by inhibiting the expression of SOX2/OCT4

Triple-negative breast cancer (TNBC) has the poorest prognosis among all types of breast cancer and there is yet no effective therapy. Chemotherapy is the traditional standard of care for patients with TNBC; however, treatment of TNBC with chemotherapy may lead to the enrichment of cancer stem cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fei, Zhu, Li, Hu, Junyan, Jiang, Shujun, Liu, Hui, Zheng, Jie, Wang, Jiandong, Wang, Feng, Li, Zhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471667/
https://www.ncbi.nlm.nih.gov/pubmed/32934738
http://dx.doi.org/10.3892/ol.2020.12028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471667/
https://www.ncbi.nlm.nih.gov/pubmed/32934738
http://dx.doi.org/10.3892/ol.2020.12028

Ejemplares similares